Mirati Therapeutics reported $1.25B in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agios Pharmaceuticals AGIO:US $ 1124.07M 83.38M
Alnylam Pharmaceuticals ALNY:US $ 176.04M 225.13M
Amgen AMGN:US $ 2419M 1503M
Astellas Pharma 4503:JP Y 1539052M 78744M
AstraZeneca AZN:LN 35932M 408M
Bayer BAYN:GR € 38019M 582M
Biocryst Pharmaceuticals BCRX:US $ -213.23M 49.02M
Bluebird Bio BLUE:US $ 180.12M 83.14M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Eisai 4523:JP Y 804545M 55723M
Eli Lilly And LLY:US $ 8544.7M 786.1M
Exelixis EXEL:US $ 2391.26M 97.41M
Gilead Sciences GILD:US $ 20215M 288M
GlaxoSmithKline GSK:LN 16374M 193M
Moderna Inc MRNA:US 17.98B 910M
Nektar Therapeutics NKTR:US $ 458.73M 149.16M
Novartis NOVN:VX SF 62925M 1385M
Puma Biotechnology PBYI:US $ 19.74M 12.59M
Sarepta Therapeutics SRPT:US $ 726.46M 130.43M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
Spectrum Pharmaceuticals SPPI:US $ 33.44M 21.81M
Takeda 4502:JP Y 6316832M 633813M
Ultragenyx Pharmaceutical RARE:US $ 678.07M 118.35M
YTE INCY:US $ 4085.06M 221.99M